TRAP1 and glioblastoma: A transcriptome with subsequent gene set enrichment analysis demonstrated that stem-like glioblastoma (GBM) cells, NCH644, that were treated with a low concentration of TRAP1—inhibitor gamitrinib—displayed down regulated gene sets related to cholesterol and mevalonate biosynthesis (Figure 1a,b,d).